Comparative Transcriptome Analyses in Mantle Cell Lymphoma (MCL): Evidence of E2F1 As a Major Target in Aggressive Blastoid MCL Model
Jusuf Imeri(Inserm), Ali G. Turhan(Inserm), Paul Marcoux(Stanford University), Amen Allah Nasr(Bicêtre Hospital), Radhia M’kacher(Genopole (France)), Annelise Bennaceur‐Griscelli(Inserm), Christophe Desterke(Université Paris-Saclay)
Cited by 0
Related Papers
Treatment of a genetic brain disease by CNS-wide microglia replacement
|Science Translational Medicine|2022|126
Serum 2-Hydroxyglutarate Production in <i>IDH1</i>- and <i>IDH2</i>-Mutated De Novo Acute Myeloid Leukemia: A Study by the Acute Leukemia French Association Group
|Journal of Clinical Oncology|2013|117
Telomere Shortening and Associated Chromosomal Instability in Peripheral Blood Lymphocytes of Patients With Hodgkin’s Lymphoma Prior to Any Treatment Are Predictive of Second Cancers
|International Journal of Radiation Oncology*Biology*Physics|2007|68
New tool for biological dosimetry: Reevaluation and automation of the gold standard method following telomere and centromere staining
|Mutation research. Fundamental and molecular mechanisms of mutagenesis|2014|65
Integration of new biological and physical retrospective dosimetry methods into EU emergency response plans – joint RENEB and EURADOS inter-laboratory comparisons
|International Journal of Radiation Biology|2016|63